Just over 15 months on dut (fin previously), 2 years ru58841/min combo , 2 years oral min AMA
    3/10/2026

    From the encyclopedia
    Dutasteride β†’

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Finasteride β†’

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    RU58841 β†’

    Experimental topical anti-androgen sold as a research chemical

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 15 months
    πŸ’Š Finasteride (oral)
    πŸ’§ RU58841 (topical) 2 years
    πŸ’§ Minoxidil (topical) 2 years
    β€’ Microneedling infrequently, usually every 2 weeks
    the tone is mixed with maintained hair, struggles with hairline thickening results.

    Other terms

    The user has been using dutasteride, RU58841, and minoxidil for hair loss, experiencing some side effects and mixed results, with RU58841 notably reducing scalp itch. Despite extensive treatment, the user has maintained hair but struggles with hairline thickening.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Hair loss and herbs for treatment

      39 citations , September 2013 in “Journal of Cosmetic Dermatology”
      This review summarizes causes and treatments of androgenetic alopecia with a focus on herbs as potential alternatives, but reports no new results and suggests more research is needed to validate these options.

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.

      research Π’Ρ–Π΅ Modern treatment of androgenetic alopecia

      February 2017 in “Vestnik dermatologii i venerologii”
      This review examines the molecular mechanisms and current treatment options for androgenetic alopecia, highlighting potential future therapies but providing no new experimental findings.

      research Therapeutic strategies for treating hair loss

      42 citations , March 2006 in “Drug Discovery Today: Therapeutic Strategies”
      This article discusses the need for rational strategies in developing hair loss drugs targeting specific events in hair follicle cycling, reporting no clinical findings but emphasizing the importance of understanding molecular controls.

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.